The disclosed compounds are useful in the treatment of mammalian cancers and especially human cancers. Compounds pharmaceutical compositions and methods of Formula I are disclosed: Formula I or a pharmaceutically acceptable salt hydrate solvate enantiomer stereoisomer or tautomer thereof.